[Tickers Inside] 7 Solid Gainers Over the Last 5 Sessions

Stocks with 5 days of consecutive price advances. --------------------------------------------------------------- [The Coming Copper Bull Run]() [Find out how you can slip into copper through the back door.]( --------------------------------------------------------------- October 18, 2022 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers of all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- [The Humble Mineral at the Heart of the EV Revolution (Not Lithium)]( may know of graphite as what's in the tip of a No. 2 pencil, but it is the key to many forms of renewable energy. Today, this humble mineral is at the epicenter of the electric car revolution. Because what most people don't know is today's EV batteries contain more than 220 pounds of graphite ñ more than lithium, copper or aluminum! [Get the Full Story On This New American Graphite Opportunity.]( --------------------------------------------------------------- [AVEO Pharma, AVEO](=) Recent Analyst Action: Andrew Berens, analyst at SVB Securities, reiterates coverage on [AVEO Pharma (AVEO)](=)in the Healthcare sector with a Buy rating (6 days ago). - Recent Price: $14.74 - Average Analyst Price Target: $15.67 (6.31%) - Market Cap: $362.76M [TipRanks.com]() also reports that [AVEO Pharma](=)currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $15.67. The target pricing ranges from a high forecast of $17.00 down to a low forecast of $15.00. [AVEO Pharma (AVEO)](=)’s last closing price was $14.74 which would put the average price target at $15.67. Here are 3rd party ratings for [AVEO](=): - TipRanks.com: Strong Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 23% (57 out of 250) [Click here for chart >>](=) -------------------------------------------------------------------------- --------------------------------------------------------------- [Wall Street Legend Warns "Financial Reset" is Coming]( Get out of U.S. banks immediately and move your money into a new vehicle 50 years in the making. --------------------------------------------------------------- [Service Properties, SVC](=) Recent Analyst Action: Dori Kesten, analyst at Wells Fargo, reiterates coverage on [Service Properties (SVC)](in the Financial sector with a Sell rating and a price target of $6.75 (1 month ago). - Recent Price: $7.93 - Average Analyst Price Target: $6.75 (-14.88%) - Market Cap: $1.28B [TipRanks.com]( also reports that [Service Properties](currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Sell rating with an average price target is $6.75. The target pricing ranges from a high forecast of $6.75 down to a low forecast of $6.75. [Service Properties (SVC)](’s last closing price was $7.93 which would put the average price target at $6.75. Here are 3rd party ratings for [SVC](: - TipRanks.com: Moderate Sell - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Buy, Top 36% (90 out of 250) [Click here for chart >>]( -------------------------------------------------------------------------- [Sonder Holdings, SOND](=) Recent Analyst Action: Nicholas Jones, analyst at JMP Securities, reiterates coverage on [Sonder Holdings (SOND)]()in the Services sector with a Buy rating and a price target of $3.5 (2 months ago). - Recent Price: $2.185 - Average Analyst Price Target: $3.50 (60.18%) - Market Cap: $476.23M [TipRanks.com]() also reports that [Sonder Holdings](=)currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $3.50. The target pricing ranges from a high forecast of $3.50 down to a low forecast of $3.50. [Sonder Holdings (SOND)](’s last closing price was $2.185 which would put the average price target at $3.50. Here are 3rd party ratings for [SOND](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Hold, Bottom 47% (132 out of 250) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [Is President Biden Finished Because of THIS?](=) =Polling shows the Biden administration is in big trouble. But what’s the REAL reason why Biden could resign in the next 30 days? According to Andrew Zatlin, a Bloomberg #1 ranked economist, the one issue which could trigger Biden’s resignation is surprising: It will likely NOT be related to inflation, rising gas prices, or cognitive health problems… [Go Here Now to Find Out The Surprising “Why” Biden Could Be Finished, How this New Crisis Could Play out With Disastrous Consequences for America…](=) [click](=) --------------------------------------------------------------- [BeiGene, BGNE]( Recent Analyst Action: Michael Schmidt, analyst at Guggenheim, reiterates coverage on [BeiGene (BGNE)](in the Healthcare sector with a Buy rating and a price target of $205.00 (5 days ago). - Recent Price: $169.39 - Average Analyst Price Target: $248.27 (46.57%) - Market Cap: $34.15B [TipRanks.com]( also reports that [BeiGene](=)currently has 7 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $248.27. The target pricing ranges from a high forecast of $296.00 down to a low forecast of $200.00. [BeiGene (BGNE)](=)’s last closing price was $169.39 which would put the average price target at $248.27. Here are 3rd party ratings for [BGNE](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Hold, Top 23% (57 out of 250) [Click here for chart >>](=) -------------------------------------------------------------------------- [Viking Therapeutics, VKTX]() Recent Analyst Action: Thomas Smith, analyst at SVB Securities, reiterates coverage on [Viking Therapeutics (VKTX)]()in the Healthcare sector with a Buy rating and a price target of $12.00 (1 week ago). - Recent Price: $4.08 - Average Analyst Price Target: $15.75 (286.03%) - Market Cap: $288.35M [TipRanks.com]( also reports that [Viking Therapeutics](=)currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $15.75. The target pricing ranges from a high forecast of $21.00 down to a low forecast of $10.00. [Viking Therapeutics (VKTX)](=)’s last closing price was $4.08 which would put the average price target at $15.75. Here are 3rd party ratings for [VKTX](): - TipRanks.com: Strong Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: buy - Zacks.com: Hold, Top 23% (57 out of 250) [Click here for chart >>]() -------------------------------------------------------------------------- --------------------------------------------------------------- [Why is Russia reopening dormant copper mines?]( In deepest Siberia, Russian oligarchs are pouring $15 billion into two long-dormant copper mines with close access to the lucrative China market. Copper is essential to the West's plans to transition to green energy and Russia has the third-largest reserves in the world. Is Putin making a move to corner the copper market? New sources of copper – outside Russia – are desperately needed for the West to win its war for energy independence. [Here's where to look]() --------------------------------------------------------------- [Kymera Therapeutics, KYMR]() Recent Analyst Action: Zhiqiang Shu, analyst at Berenberg Bank, reiterates coverage on [Kymera Therapeutics (KYMR)]()in the Healthcare sector with a Buy rating and a price target of $68.00 (1 day ago). - Recent Price: $26.055 - Average Analyst Price Target: $56.50 (116.85%) - Market Cap: $1.31B [TipRanks.com]() also reports that [Kymera Therapeutics]()currently has 9 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $56.50. The target pricing ranges from a high forecast of $93.00 down to a low forecast of $37.00. [Kymera Therapeutics (KYMR)]()’s last closing price was $26.055 which would put the average price target at $56.50. Here are 3rd party ratings for [KYMR](): - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Hold, Top 23% (57 out of 250) [Click here for chart >>]() -------------------------------------------------------------------------- [Verrica Pharmaceuticals, VRCA](=) Recent Analyst Action: Oren Livnat, analyst at H.C. Wainwright, reiterates coverage on [Verrica Pharmaceuticals (VRCA)](=)in the Healthcare sector with a Buy rating and a price target of $11.00 (2 months ago). - Recent Price: $3.14 - Average Analyst Price Target: $7.50 (138.85%) - Market Cap: $120.41M [TipRanks.com]( also reports that [Verrica Pharmaceuticals](=)currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $7.50. The target pricing ranges from a high forecast of $11.00 down to a low forecast of $4.00. [Verrica Pharmaceuticals (VRCA)](=)’s last closing price was $3.14 which would put the average price target at $7.50. Here are 3rd party ratings for [VRCA](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Top 31% (77 out of 250) [Click here for chart >>](=) -------------------------------------------------------------------------- --------------------------------------------------------------- ["TAKE THAT, CHINA!" USA Gains in EV Battery Arms Race]( you know each electric car battery requires 220 pounds of graphite ñ more than lithium, copper, or aluminum? China enjoyed a "near monopoly" in this vital ingredient... until the U.S. made a blockbuster announcement. Now one little-known company is set to play a crucial role in the booming $7 trillion EV revolution. [Get the full story on this new North American graphite opportunity]( --------------------------------------------------------------- And there you have it--7 Five Day Gainers of all US Exchanges. Sincerely, The Editor, MarketSectorDaily.com [Unsubscribe](=) Sandpiper Marketing Group, LLC PO Box 407 Mt. Mourne, North Carolina 28123 United States (845) 803-0954 If you no longer wish to receive our emails, click the link below: [Unsubscribe]( MarketSectorDaily.com part of Sandpiper Marketing Group, LLC 165 Lockerbie Lane Mooresville, North Carolina 28115 United States (877) 411-9808